Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

GSIE Benefits From Surging Interest in International Equities

BY | ETF Database
2:49 pm ET 10/30/26 | 5 VIEWS
Investor interest in international equities has been one of the prevailing stories of 2026, due to years of domestic growth and the recent outsized dominance of U.S. megacap technology stocks.One fund that has reflected the demand in international equities is the Goldman Sachs ActiveBeta International Equity ETF (GSIE A-), the fifth largest in AUM total of the company’s ETF suite. GSIE was one of the suites largest growers in June 2025, when the firms total AUM rose above $50 billion briefly, thanks to benefits it saw from the year’s foreign equity spike.Key Takeaways: GSIE combines value, quality, momentum, and low-volatility sub-indices to offer a multi-factor alternative to standard market-cap-weighted international funds. The fund has pulled in hundreds of millions in year-to-date inflows, pushing its assets under management near the $6 billion mark. GSIE spreads capital across more than 630 individual stocks in regions like Japan, the U.K., and Western Europe. It tilts heavily toward financials and technology. GSIE has taken in roughly $680 million in net flows for the year so far, according to VettaFi data. That steady accumulation in net inflows for the year has expanded GSIE’s asset base to approximately $5.93 billion in AUM. The ETF’s underlying index is reconstituted and rebalanced quarterly, and the fund charges a 0.25% expense ratio.A Factor Tilt, Not Plain Cap-WeightGSIE is not a standard market-cap weighted international fund. It tracks the Stuttgart Goldman Sachs ActiveBeta Intl. Equity index, which equally blends four factor sub-indices: value, quality, momentum and low volatility. This design appears to be the appeal for investors. Advisors who want to add non-U.S. exposure may prefer a built-in tilt over simply owning whatever the cap-weighted market delivers. Among GSIE’S top 10 holdings are names familiar to investors. Those include ASML (2.24%), Novartis AG (1.06%), and HSBC (0.99%). Its sector tilt leans towards financials (29.55%), health technology (8.48%), and electronic technology (7.26%).Where the Exposure Sits: Inside GSIE’s EngineBeyond the flow data and macro narrative, the real operational story of GSIE is where and how it deploys capital. Rather than mirroring market-cap-weighted international indexes that overweight sluggish foreign giants, the fund’s multi-factor engine pulls its holdings from a range of geographic, sector, and fundamental pockets. The value and quality sleeves of the index tilt the portfolio toward fundamentally sound companies with attractive pricing and robust balance sheets. Meanwhile, the momentum and low-volatility sleeves capture upward price trends and dampen wild market swings. GSIE’s portfolio holds over 630 individual stocks spread across developed international regions. Its strong baselines lie in Japan, the U.K., Canada, and Western Europe. GSIE’s asset accumulation in 2026 underscores a broader shift among advisors who are looking beyond traditional cap-weighted benchmarks to get more effective exposure to markets and diversify away from domestic assets. By blending multi-factor design with broad global exposure, the fund bridges the gap between passive cost efficiency and active tactical positioning. For a fund sitting near $6 billion in assets, this current wave of inflows suggests that smart-beta international strategies are moving from alternative sleeve to core portfolio staple. For more news, information, and strategy, visit the Future ETFs Content Hub.

More Commentary

Inside the Ticker: IEMG vs. VWO
BY | ETF Database
5:35 am ET 10/30/26 | 27 VIEWS
Make Meta Marvelous With This Income ETF
BY | ETF Database
6:17 am ET 10/30/26 | 39 VIEWS
Pairing Quality Growth & High Yields: A Blueprint for All-Weather Portfolios
BY | ETF Database
6:04 am ET 10/30/26 | 60 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.